• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外周血管扩张剂14C-美西那酮(14C-6809 MD)在大鼠、狗和人体中的吸收与排泄。

The absorption and excretion of the peripheral vasodilator 14C-mecinarone, (14C-6809 MD) in rat, dog and man.

作者信息

Hawkins D R, Weston K T, Chasseaud L F, Darragh A, O'Kelly A

出版信息

Eur J Drug Metab Pharmacokinet. 1980;5(3):135-43. doi: 10.1007/BF03189457.

DOI:10.1007/BF03189457
PMID:7202431
Abstract

Oral doses of the peripheral vasodilator mecinarone (6809 MD), administered as the 14C-compound, were well absorbed from the gastrointestinal tract of rats, dogs and humans. Much of the dose was excreted in 24 by rats and dogs, but more slowly by humans. In 5 days, rats, dogs and humans excreted in the urine and faeces respectively means of 3.3 and 95.9%, 13.2 and 80.3%, and 22.0 and 60.8%. The proportions of radioactivity excreted in urine and faeces after intravenous doses were similar to those after oral doses, means of 3.1 and 85.0% respectively by rats and 16.8 and 78.3% by dogs. Radioactivity present in the faeces was probably mainly excreted in bile; rats (n = 2) excreted a mean of 52.3, 19.8 and 3.9% in bile, faeces and urine after oral doses. Plasma concentrations of radioactivity after oral doses reached a maximum at 1 h in rats (mean 126 ng equiv/ml), at 1 to 2 h in dogs (mean 784 ng equiv/ml) and at 1.5 to 2 h in humans (mean 547 ng equiv/ml. Only a small proportion of this radioactivity (10-30%) represented unchanged drug. When "normalised" for dose/bodyweight differences, those levels were in the ratio 1 : 7 : 32 (rat less than dog less than man). Areas under plasma radioactivity concentration-time curves after oral doses to rats and dogs were about 25% and 53% respectively of those after corresponding intravenous doses. Only about 20% of the radioactivity in the plasma of dogs at 2 min after an intravenous dose represented unchanged drug. These data suggest that 6890 MD was probably rapidly biotransformed in rat, dog and man.

摘要

以14C标记化合物形式口服外周血管扩张剂美西那龙(6809 MD)后,大鼠、狗和人类胃肠道对其吸收良好。大鼠和狗在24小时内排出了大部分剂量,但人类排出速度较慢。5天内,大鼠、狗和人类分别通过尿液和粪便排出的剂量均值为3.3%和95.9%、13.2%和80.3%、22.0%和60.8%。静脉给药后尿液和粪便中排出的放射性比例与口服给药后相似,大鼠分别为3.1%和85.0%,狗分别为16.8%和78.3%。粪便中的放射性可能主要通过胆汁排出;口服给药后,大鼠(n = 2)胆汁、粪便和尿液中的排出均值分别为52.3%、19.8%和3.9%。口服给药后,大鼠血浆放射性浓度在1小时达到峰值(均值126 ng当量/ml),狗在1至2小时达到峰值(均值784 ng当量/ml),人类在1.5至2小时达到峰值(均值547 ng当量/ml)。该放射性中只有一小部分(10 - 30%)代表未变化的药物。当根据剂量/体重差异进行“标准化”后,这些水平的比例为1 : 7 : 32(大鼠<狗<人)。大鼠和狗口服给药后血浆放射性浓度-时间曲线下面积分别约为相应静脉给药后的25%和53%。静脉给药后2分钟,狗血浆中只有约20%的放射性代表未变化的药物。这些数据表明,6890 MD在大鼠、狗和人类体内可能迅速发生生物转化。

相似文献

1
The absorption and excretion of the peripheral vasodilator 14C-mecinarone, (14C-6809 MD) in rat, dog and man.外周血管扩张剂14C-美西那酮(14C-6809 MD)在大鼠、狗和人体中的吸收与排泄。
Eur J Drug Metab Pharmacokinet. 1980;5(3):135-43. doi: 10.1007/BF03189457.
2
Aspects of the metabolism of the peripheral vasodilator mecinarone (14C-6809 MD) in rat, dog and man.外周血管扩张剂美西那酮(14C-6809 MD)在大鼠、狗和人体内的代谢情况。
Eur J Drug Metab Pharmacokinet. 1980;5(3):145-52. doi: 10.1007/BF03189458.
3
The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.抗蠕虫药甲基-14C-5-环丙基羰基-2-苯并咪唑氨基甲酸酯(环苯达唑)对大鼠和犬给药后的放射性分布情况。
Arzneimittelforschung. 1977;27(3):593-8.
4
Metabolic fate of the thrombolytic agent benzarone in man: comparison with the rat and dog.溶栓剂苄佐那在人体内的代谢转归:与大鼠和犬的比较。
Xenobiotica. 1987 Jul;17(7):881-96. doi: 10.3109/00498258709043998.
5
Metabolism of labetalol by animals and man.拉贝洛尔在动物和人体内的代谢。
Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):695-710.
6
Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.大鼠、犬和猴单次口服给予[羰基-14C]枸橼酸莫沙必利后的吸收、分布及排泄情况。
Arzneimittelforschung. 1993 Oct;43(10):1084-94.
7
Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.新型降胆固醇化合物S-8921在大鼠和犬体内的处置与代谢
Arzneimittelforschung. 1998 Oct;48(10):995-1006.
8
Pharmacokinetics of nisoldipine. I. Absorption, concentration in plasma, and excretion after single administration of [14C]nisoldipine in rats, dogs, monkey, and swine.尼索地平的药代动力学。I. 大鼠、狗、猴和猪单次给予[14C]尼索地平后的吸收、血浆浓度及排泄
Arzneimittelforschung. 1988 Aug;38(8):1093-8.
9
Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.新型认知增强剂NS-105的药代动力学。首次通讯:单次给予14C-NS-105后在大鼠、犬和猴体内的吸收、代谢及排泄情况
Arzneimittelforschung. 1999 Nov;49(11):881-90. doi: 10.1055/s-0031-1300521.
10
Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.4-乙酰氨基苯乙酸的药代动力学。首次通讯:单次给予14C标记化合物后在小鼠、大鼠、狗和猴体内的吸收、分布、代谢及排泄情况
Arzneimittelforschung. 1990 Jul;40(7):800-5.

引用本文的文献

1
Aspects of the metabolism of the peripheral vasodilator mecinarone (14C-6809 MD) in rat, dog and man.外周血管扩张剂美西那酮(14C-6809 MD)在大鼠、狗和人体内的代谢情况。
Eur J Drug Metab Pharmacokinet. 1980;5(3):145-52. doi: 10.1007/BF03189458.

本文引用的文献

1
MEASUREMENT OF LOW ENERGY BETA-EMITTERS IN AQUEOUS SOLUTION BY LIQUID SCINTILLATION COUNTING OF EMULSIONS.通过乳液的液体闪烁计数法测量水溶液中的低能β发射体。
Anal Chem. 1965 Jun;37:854-7. doi: 10.1021/ac60226a017.
2
The metabolic fate of the coronary dilator 4-(3,4,5,-trimethoxycinnamoyl)-1-(N-isopropylcarbamoylmethyl)-piperazine in the rat, dog and man.冠状动脉扩张剂4-(3,4,5-三甲氧基肉桂酰基)-1-(N-异丙基氨甲酰基甲基)哌嗪在大鼠、狗和人体内的代谢命运。
Xenobiotica. 1974 Jul;4(7):393-407. doi: 10.3109/00498257409052104.
3
Pharmacological study of a new substance, mecinarone.
Arzneimittelforschung. 1975 May;25(5):782-6.